The persistence of red cell alloantibodies

Blood Transfusion

Volumn 6, Issue 4, 2008, Pages 225-234

  Reverberi, Roberto ^a,b  

^a UNIVERSITY OF FERRARA   (Italy)

^b UNIVERSITY HOSPITAL OF FERRARA   (Italy)

Author keywords

Antibody persistence; Immunohaematology; Non persistent antibodies; Red cell antibodies

Indexed keywords

ALLOANTIBODY; ANTIBODY; ANTIBODY C; ANTIBODY CE; ANTIBODY CH; ANTIBODY CO; ANTIBODY DI; ANTIBODY E; ANTIBODY F; ANTIBODY FY; ANTIBODY JK; ANTIBODY JS; ANTIBODY K; ANTIBODY KP; ANTIBODY LE; ANTIBODY LU; ANTIBODY M; ANTIBODY N; ANTIBODY S; ANTIBODY WR; ANTIBODY XG; RED CELL ALLOANTIBODY; RHESUS ANTIBODY; RHESUS D ANTIBODY; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIBODY DETECTION; ANTIBODY PRODUCTION; ANTIBODY SCREENING; ANTIBODY SPECIFICITY; BETA THALASSEMIA; BLOOD GROUP ABO SYSTEM; BLOOD GROUP DUFFY SYSTEM; BLOOD GROUP KELL SYSTEM; BLOOD GROUP KIDD SYSTEM; BLOOD GROUP LEWIS SYSTEM; BLOOD GROUP LUTHERAN SYSTEM; BLOOD GROUP MNSS SYSTEM; BLOOD SAMPLING; BLOOD TRANSFUSION; CONFERENCE PAPER; FEMALE; FOLLOW UP; HUMAN; IMMUNOASSAY; MAJOR CLINICAL STUDY; MALE; SENSITIVITY ANALYSIS;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTIBODY SPECIFICITY; EFFECT MODIFIERS (EPIDEMIOLOGY); ERYTHROCYTES; FEMALE; FOLLOW-UP STUDIES; HUMANS; ISOANTIBODIES; MALE; MIDDLE AGED; SENSITIVITY AND SPECIFICITY; SEX FACTORS; TIME FACTORS;

EID: 56649123221     PISSN: 17232007     EISSN: None     Source Type: Journal    
DOI: 10.2450/2008.0021-08     Document Type: Conference Paper

References (14)

1. th ed, Oxford, Great Britain, Blackwell Science, 2005.
2. Engelfriet CP, Reesink HW. International Forum: prevention and diagnosis of haemolytic transfusion reactions. Vox Sang 2006; 91:353-68.
3. Ramsey G, Larson P. Loss of red cell antibodies over time. Transfusion 1988; 28:162-5.
4. Ramsey G, Smietana SJ. Long-term follow-up testing of red cell alloantibodies. Transfusion 1994; 34:122-4.
5. Schonewille H, Haak HL, van Zijl AM. RBC antibody persistence. Transfusion 2000; 40:1127-31.
6. Rosse WF, Gallagher D, Kinney TR, et al. Transfusion and alloimmunization in sickle cell disease. The Cooperative Study of Sickle Cell Disease. Blood 1990; 76:1431-7.
7. Reverberi R, Ferrari L, Balugani S. Fattori che influenzano la sensibilità dei test per gli anticorpi anti-eritrocitari: confronto tra bassa e bassissima forza ionica e tra protamina ed anti-IgG. La Trasfusione del Sangue 1996; 41:10-6.
8. Verenini M, Reverberi R. Uso del PEG in immunoematologia: ottimizzazione della tecnica. La Trasfusione del Sangue 1997; 42:220-4.
9. Aickin M, Gensler H. Adjusting for multiple testing when reporting research results: the Bonferroni vs Holm methods. Am J Public Health 1996; 86:726-8.
10. Engelfriet CP, Overbeeke MAM. The persistence of blood group antibodies. Transfusion 1994; 34:98-9.
11. Hutchison HE, McLennan W. Long persistence of Rhesus antibodies. Vox Sang 1966; 11:517-8.
12. b persisting for sixteen years (letter). Transfusion 1983; 23:362.
13. Taswell HF, Pineda AA, Moore SB. Haemolytic transfusion reactions: frequency and clinical and laboratory aspects. In: Bell CA, editor: A seminar on immune-mediated cell destruction. Chicago, IL, AABB, 1981.
14. Rubinstein P. Cyclical variations in anti-Rh titer detected by automatic quantitative hemagglutination. Vox Sang 1972; 23:508-22.